HHealthcare Read More Roche moves obesity drug to pivotal trials after mid-stage successJanuary 27, 2026 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
MMedication Read More Japan to designate eight ingredients for list of drugs with abuse riskJanuary 25, 2026 The health ministry will designate eight drug ingredients as having abuse potential under the law in response to…
HHealthcare Read More Next steps for Eli Lilly, Novo Nordisk, PfizerJanuary 23, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George…
MMedication Read More Number of new U.S. drug shortages hits lowest level in 20 yearsJanuary 23, 2026 The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
HHealthcare Read More J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.January 21, 2026 Last Updated: Jan. 21, 2026 at 10:14 a.m. ETFirst Published: Jan. 21, 2026 at 7:26 a.m. ET Johnson & Johnson…
HHealthcare Read More Another alliance of health care and AI signals why pharma stocks could be backJanuary 20, 2026 Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
MMedication Read More Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods insteadJanuary 15, 2026 Published: Jan. 15, 2026 at 11:51 a.m. ET Millions of Americans have tried GLP-1s, but some people find that…
HHealthcare Read More Johnson & Johnson, U.S. agree on drug discounts, new plantsJanuary 9, 2026 Key Terms tariffs regulatory Tariffs are taxes imposed by a government on goods…
MMental health Read More Kennedy’s SSRI rhetoric fuels distrust amid teen mental health crisisJanuary 7, 2026 While his war on vaccines may be getting more attention, health secretary Robert F. Kennedy Jr. is coming…
HHealthcare Read More First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.January 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…
MMedication Read More Novo Nordisk beyond weight loss has investors wary, scientists hopefulJanuary 1, 2026 Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…